These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 4130627

  • 1. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S, Lober M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract] [Full Text] [Related]

  • 2. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG, Brunswig D, Liehr H.
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [Abstract] [Full Text] [Related]

  • 3. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML, Pizzo SV, Hill RL, McKee PA.
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [Abstract] [Full Text] [Related]

  • 4. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE, Santiago MA, Greenberg CS.
    Anal Biochem; 1994 May 15; 219(1):43-8. PubMed ID: 8059954
    [Abstract] [Full Text] [Related]

  • 5. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP, Zhukova NA.
    Probl Gematol Pereliv Krovi; 1973 Feb 15; 18(2):34-40. PubMed ID: 4271843
    [No Abstract] [Full Text] [Related]

  • 6. Factor XIII-activity and fibrin subunit structure in acute leukemia.
    Rasche H, Dietrich M, Gaus W, Schleyer M.
    Biomedicine; 1974 Feb 15; 21(2):61-6. PubMed ID: 4527804
    [No Abstract] [Full Text] [Related]

  • 7. [Identification of a (D-D)...E complex in degradation products of bovine fibrin stabilized by factor XIII].
    Hudry-Clergeon G, Paturel L, Suscillon M.
    Pathol Biol (Paris); 1974 Nov 15; 22 suppl():47-52. PubMed ID: 4620095
    [No Abstract] [Full Text] [Related]

  • 8. [Analysis of reduced human fibrin by polyacrylamide gel electrophoresis (author's transl)].
    Rasche H, Schleyer M, Dietrich M.
    Klin Wochenschr; 1974 Mar 01; 52(5):233-7. PubMed ID: 4835639
    [No Abstract] [Full Text] [Related]

  • 9. [Zone-electrophoretic, chromatographic and spectrographic studies on fibrinogens of normal and cobalt treated rabbits].
    Krantz S, Fiedler H, Lober M.
    Acta Biol Med Ger; 1970 Mar 01; 25(4):523-37. PubMed ID: 5518786
    [No Abstract] [Full Text] [Related]

  • 10. Fibrinogen and its derivatives, hereditary and acquired abnormalities.
    Marder VJ, Buszynski AZ.
    Schweiz Med Wochenschr; 1974 Sep 28; 104(39):1338-42. PubMed ID: 4421373
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of crosslinked and noncrosslinked fibrin from the major classes of vertebrates.
    Schwartz ML, Pizzo SV, Sullivan JB, Hill RL, McKee PA.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):313-38. PubMed ID: 4762256
    [No Abstract] [Full Text] [Related]

  • 12. Subunit structure of fragment D from fibrinogen and cross-linked fibrin.
    Pizzo SV, Taylor LM, Schwartz ML, Hill RL, McKee PA.
    J Biol Chem; 1973 Jul 10; 248(13):4584-90. PubMed ID: 4198060
    [No Abstract] [Full Text] [Related]

  • 13. [Isolation and characterization of fibrinogen from plasma of normal and cobalt treated rabbits by affinity chromatography and electrophoresis in dodecyl sulfate containing polyacrylamide gels].
    Krantz S, Lober M.
    Acta Biol Med Ger; 1978 Jul 10; 37(4):545-51. PubMed ID: 735624
    [No Abstract] [Full Text] [Related]

  • 14. [Relation between fibrinogen concentration, fibrin-stabilizing factor activity and fibrinolysis in hemorrhagic disease in children].
    Bebeshko VG, Donskaia SB.
    Lab Delo; 1987 Jul 10; (7):520-2. PubMed ID: 2442484
    [No Abstract] [Full Text] [Related]

  • 15. Gel electrophoresis for assessing fibrin crosslinking: a precaution.
    Finlayson JS, Morton RO.
    Clin Chim Acta; 1972 Jan 10; 36(1):254-6. PubMed ID: 4621428
    [No Abstract] [Full Text] [Related]

  • 16. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB, Stathakis NE.
    Thromb Haemost; 1980 Dec 19; 44(3):130-4. PubMed ID: 6162208
    [Abstract] [Full Text] [Related]

  • 17. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW, Nachman RL, Marder VJ.
    Thromb Haemost; 1984 Feb 28; 51(1):84-8. PubMed ID: 6719392
    [Abstract] [Full Text] [Related]

  • 18. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR, Meh DA, Mosesson MW.
    Thromb Haemost; 2001 Nov 28; 86(5):1221-8. PubMed ID: 11816711
    [Abstract] [Full Text] [Related]

  • 19. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA, Fisher LM.
    Va Med Mon (1918); 1970 May 28; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract] [Full Text] [Related]

  • 20. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM, Kudriashov BA, Liapina LA.
    Biokhimiia; 1973 May 28; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.